Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?
April 22, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs
10 min read
False
April 22, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs
10 min read
April 21, 2026
Why temperature-controlled logistics is a critical but overlooked foundation of equitable access to medicines
4 min read
April 21, 2026
Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma
3 min read
April 20, 2026
Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T
4 min read
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
April 17, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
2 min read
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
April 15, 2026
A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
5 min read
April 15, 2026
How to turn regulatory complexity into strategic strength
7 min read
April 14, 2026
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
4 min read
False
False
False